Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine mixed with propofol to prevent propofol injection pain
ChiCTR2100048219Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine (4 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Pain during propofol injection. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2100048219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048219.